Co-expression Model and Inhibitor Screening of the Human P450 CYP2C19 with the CYPOR and CYPb5

Su Zeng

2012-01-01

Abstract:Objective:To obtain recombinant human CYP2C19,in order to determine its activity by using a specific probe substrate,and to employ it for in vitro inhibitor screening for the natural product.Method:The Bac-to-Bac baculovirus expression system was used to co-express recombinant CYP2C19 with CYPOR and CYPb5.The His-tagged recombinant CYP2C19 was detected by Western Blot using anti-His antibody.The enzyme activity was determined by HPLC using omeprazole as a probe substrate.Then the recombinant enzyme was used to screen the inhibition activities to CYP2C19 of 70 phytochemicals.Result:The expression of CYP2C19 was detected by Western blot analysis.The Km,Vmax and CLint were(4.99±0.22) μmol·L-1,(0.2539±0.0024) μmol·min-1·mg-1 protein,and 0.0509 L·min-1·mg-1 protein,respectively.The inhibitor screening analyses revealed that resveratrol,emodin,isoalantolactone,curcumol,DL-menthol,podophyllotoxin,psoralen,schisandrin A,schisandrin B and chamaejasmine B showed inhibition to CYP2C19.Conclusion:Active recombinant CYP2C19 was obtained by Bac-to-Bac expression system,and it would facilitate much in studies of phase Ⅰ metabolism and inhibitors screening in vitro.